Scott T. Rottinghaus, Chief Medical Officer at ENANTA PHARMACEUTICALS INC (ENTA), sold 798 shares at $14.23 ($11K) on 2025-12-05, disclosed to the SEC on 2025-12-05.
Open-market sale of $11k ENTA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ENTA | SELL | 2023-12-06 | $5K | — | Filing → |